The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells

LEUKEMIA

NATURE PUBLISHING GROUP

1. NCI NIH HHS [P01 CA95426, P01 CA095426, P50 CA140158, P01 CA101956, P50-CA140158, P01 CA081534, K12 CA133250, P30 CA016058, P01 CA8153] Funding Source: Medline